Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study

Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detectio...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 15; no. 1; pp. 4488 - 12
Main Authors Yang, Yang, Niu, Shiyu, Shen, Chenguang, Yang, Liuqing, Song, Shuo, Peng, Yun, Xu, Yifan, Guo, Liping, Shen, Liang, Liao, Zhonghui, Liu, Jiexiang, Zhang, Shengjie, Cui, Yanxin, Chen, Jiayin, Chen, Si, Huang, Ting, Wang, Fuxiang, Lu, Hongzhou, Liu, Yingxia
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 27.05.2024
Nature Publishing Group
Nature Portfolio
Subjects
45/23
49/22
631/326/2521
631/326/596/1746
692/699/255/2514
82/1
Adult
Air conditioning
Antibodies
Antibodies, Neutralizing - blood
Antibodies, Neutralizing - immunology
Antibodies, Viral - blood
Antibodies, Viral - immunology
Antibody response
Coinfection - epidemiology
Coinfection - immunology
Coinfection - virology
Deoxyribonucleic acid
DNA
DNA, Viral
Fomites
Fomites - virology
HIV
HIV Infections - immunology
HIV Infections - virology
Human immunodeficiency virus
Humanities and Social Sciences
Humans
Immunoglobulin G
Infections
Lesions
Longitudinal Studies
Male
Middle Aged
Monkeypox virus - immunology
Mpox
Mpox, Monkeypox - epidemiology
Mpox, Monkeypox - immunology
Mpox, Monkeypox - virology
multidisciplinary
Neutralizing
Oropharynx
Oropharynx - immunology
Oropharynx - virology
Prospective Studies
Public health
Rectum
Saliva
Saliva - immunology
Saliva - virology
Science
Science (multidisciplinary)
Skin
Skin diseases
Skin lesions
Viral Load
Virus Shedding
Viruses
Online AccessGet full text

Cover

Abstract Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum. Here the authors measure viral load in samples from skin lesions, saliva, oropharynx, and rectum of 77 patients with acute monkeypox virus infection as well as from environmental fomite swabs and show a high seropositivity rate for antibodies against A29L and H3L.
AbstractList Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum.
Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum. Here the authors measure viral load in samples from skin lesions, saliva, oropharynx, and rectum of 77 patients with acute monkeypox virus infection as well as from environmental fomite swabs and show a high seropositivity rate for antibodies against A29L and H3L.
Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum.Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum.
Abstract Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum.
Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites and environmental fomites of 77 acute MPXV infections (HIV co-infection: N = 42) were collected every two to three days and used for detection of MPXV DNA, surface protein specific antibodies and neutralizing titers. Skin lesions show 100% positivity rate of MPXV DNA, followed by rectum (88.16%), saliva (83.78%) and oropharynx (78.95%). Positivity rate of oropharynx decreases rapidly after 7 days post symptom onset (d.p.o), while the rectum and saliva maintain a positivity rate similar to skin lesions. Viral dynamics are similar among skin lesions, saliva and oropharynx, with a peak at about 6 d.p.o. In contrast, viral levels in the rectum peak at the beginning of symptom onset and decrease rapidly thereafter. 52.66% of environmental fomite swabs are positive for MPXV DNA, with highest positivity rate (69.89%) from air-conditioning air outlets. High seropositivity against A29L (100%) and H3L (94.74%) are detected, while a correlation between IgG endpoint titers and neutralizing titers is only found for A29L. Most indexes are similar between HIV and Non-HIV participants, while HIV and rectitis are associated with higher viral loads in rectum.Here the authors measure viral load in samples from skin lesions, saliva, oropharynx, and rectum of 77 patients with acute monkeypox virus infection as well as from environmental fomite swabs and show a high seropositivity rate for antibodies against A29L and H3L.
ArticleNumber 4488
Author Cui, Yanxin
Lu, Hongzhou
Shen, Liang
Chen, Jiayin
Liu, Yingxia
Song, Shuo
Xu, Yifan
Niu, Shiyu
Chen, Si
Yang, Yang
Liu, Jiexiang
Peng, Yun
Guo, Liping
Yang, Liuqing
Liao, Zhonghui
Zhang, Shengjie
Huang, Ting
Wang, Fuxiang
Shen, Chenguang
Author_xml – sequence: 1
  givenname: Yang
  orcidid: 0000-0002-6489-4459
  surname: Yang
  fullname: Yang, Yang
  email: young@mail.sustech.edu.cn
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases, National Clinical Research Center for Infectious Disease
– sequence: 2
  givenname: Shiyu
  surname: Niu
  fullname: Niu, Shiyu
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases, National Clinical Research Center for Infectious Disease
– sequence: 3
  givenname: Chenguang
  orcidid: 0000-0001-8607-3750
  surname: Shen
  fullname: Shen, Chenguang
  organization: BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health; Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University
– sequence: 4
  givenname: Liuqing
  surname: Yang
  fullname: Yang, Liuqing
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 5
  givenname: Shuo
  orcidid: 0000-0002-0289-2941
  surname: Song
  fullname: Song, Shuo
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 6
  givenname: Yun
  surname: Peng
  fullname: Peng, Yun
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 7
  givenname: Yifan
  surname: Xu
  fullname: Xu, Yifan
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 8
  givenname: Liping
  surname: Guo
  fullname: Guo, Liping
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 9
  givenname: Liang
  surname: Shen
  fullname: Shen, Liang
  organization: Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
– sequence: 10
  givenname: Zhonghui
  surname: Liao
  fullname: Liao, Zhonghui
  organization: School of Public Health, Bengbu Medical College
– sequence: 11
  givenname: Jiexiang
  surname: Liu
  fullname: Liu, Jiexiang
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 12
  givenname: Shengjie
  orcidid: 0000-0001-6988-2791
  surname: Zhang
  fullname: Zhang, Shengjie
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 13
  givenname: Yanxin
  surname: Cui
  fullname: Cui, Yanxin
  organization: School of Public Health, Bengbu Medical College
– sequence: 14
  givenname: Jiayin
  surname: Chen
  fullname: Chen, Jiayin
  organization: National Clinical Research Center for Infectious Disease
– sequence: 15
  givenname: Si
  surname: Chen
  fullname: Chen, Si
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 16
  givenname: Ting
  surname: Huang
  fullname: Huang, Ting
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
– sequence: 17
  givenname: Fuxiang
  orcidid: 0000-0002-2605-3747
  surname: Wang
  fullname: Wang, Fuxiang
  email: 13927486077@163.com
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases, National Clinical Research Center for Infectious Disease
– sequence: 18
  givenname: Hongzhou
  surname: Lu
  fullname: Lu, Hongzhou
  email: luhongzhou@szsy.sustech.edu.cn
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases, National Clinical Research Center for Infectious Disease
– sequence: 19
  givenname: Yingxia
  orcidid: 0000-0001-6335-3346
  surname: Liu
  fullname: Liu, Yingxia
  email: yingxialiu@hotmail.com
  organization: Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38802350$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNUREvpC7BAltiwCfgWJ2GDqopLpZHYwNry5WTGQ8YOtjMw78BD45kppe2ilpyb___zcf7zvDrxwUNVvST4LcGse5c44aKtMeU179qG192T6oxiTmrSUnZy5_m0ukhpjctgPek4f1adsq7DlDX4rPqzCH7p8mydVyPauliuaQW2vC-R8rbM7HSwOxQhTcEnQGalojIZokvZmYTCgDbg0S-XV0iZOQNyfgCTXfCHteB_wG4Kv_f0Ob1HCk0xpGmv2BZaWIWYUSol7F5UTwc1Jri4uZ9X3z99_Hb1pV58_Xx9dbmoTcNJri2mnWCaC9MI0_atUQaYKqPXje1130BPGzqIvsWUkIYI0hIA3sOgAXRP2Hl1feTaoNZyim6j4k4G5eThQ4hLqWI52wgSOm4tVw3TauCisRqsVmpQQveUFmhhfTiypllvwBrwufzDe9D7K96t5DJsJSGEYUZFIby5IcTwc4aU5cYlA-OoPIQ5SYZFkbakxUX6-oF0HeZYkjuosCiRNnvgq7sl3dbyL_UioEeBKUGkCMOthGC57y557C5Zukseukt2xdQ9MBmX1T7lciw3Pm5lR2sq-_glxP9lP-L6CyfY6AU
CitedBy_id crossref_primary_10_1016_j_imj_2025_100166
crossref_primary_10_1515_dx_2024_0145
crossref_primary_10_1111_all_16374
crossref_primary_10_1016_j_bios_2025_117171
crossref_primary_10_1038_s41467_024_51737_4
crossref_primary_10_1016_j_dscb_2024_100169
crossref_primary_10_1016_j_ejim_2024_08_025
Cites_doi 10.1016/j.jhin.2023.03.026
10.1038/s41564-021-01051-2
10.1016/j.jinf.2023.07.017
10.1002/rmv.2404
10.1080/22221751.2023.2254407
10.1038/s41591-022-02004-w
10.1053/j.gastro.2020.05.035
10.1038/s41467-021-25997-3
10.1038/s41392-022-01166-w
10.2807/1560-7917.ES.2022.27.28.2200503
10.1016/j.bsheal.2023.08.001
10.1016/S2666-5247(22)00153-7
10.1002/jmv.28983
10.1016/S1473-3099(22)00513-8
10.1038/s41392-022-01215-4
10.1093/jtm/taad048
10.1136/bmj-2022-072410
10.1371/journal.pntd.0007791
10.2807/1560-7917.ES.2022.27.36.2200675
10.1126/science.add4507
10.1016/S0140-6736(22)01436-2
10.2807/1560-7917.ES.2022.27.35.2200636
10.1002/jmv.29140
10.1038/s41422-023-00792-5
10.15585/mmwr.mm7134e1
10.1002/jmv.28429
10.1016/j.idc.2019.03.001
10.1038/s41591-022-01907-y
10.3201/eid2812.221160
10.3390/vaccines11091420
10.1128/cmr.00092-22
10.1016/S2666-5247(23)00139-8
10.1016/S1473-3099(22)00586-2
10.1371/journal.pntd.0010141
10.1128/spectrum.00719-23
10.1016/S2666-5247(22)00286-5
10.1038/s41467-023-44092-3
10.1126/scitranslmed.adg3540
10.1080/22221751.2023.2192815
10.1016/S2666-5247(22)00382-2
10.1093/oxfordjournals.aje.a114747
10.1080/22221751.2023.2204151
10.1016/j.jhin.2023.03.009
10.1016/j.jinf.2022.12.010
10.1016/S0140-6736(22)01101-1
10.1056/NEJMoa2207323
10.1038/mi.2016.97
10.1016/S2666-5247(22)00291-9
10.1002/jmv.28851
10.1016/j.jcv.2023.105421
10.1038/s41591-022-02090-w
10.1016/S2666-5247(22)00257-9
10.1056/NEJMoa032299
10.1016/S2666-5247(23)00034-4
10.1093/jtm/taad111
10.2807/1560-7917.ES.2022.27.22.2200421
10.1016/S0140-6736(22)02075-X
10.1111/1462-2920.16129
10.1016/S1473-3099(22)00794-0
10.1016/S2666-5247(22)00259-2
10.1016/S1473-3099(22)00228-6
10.1038/s41467-023-41628-5
10.1016/j.ijbiomac.2023.125515
10.1016/S1473-3099(23)00352-3
10.1038/s41577-022-00775-4
10.1111/bjd.21790
10.15585/mmwr.mm7122e1
10.7326/M22-2183
10.1016/j.chom.2023.05.001
10.2139/ssrn.4578561
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-024-48754-8
DatabaseName Open Access Journals from Springer Nature
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Database
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Advanced Technologies & Aerospace Database (NC LIVE)
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
MEDLINE - Academic


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Public Health
EISSN 2041-1723
EndPage 12
ExternalDocumentID oai_doaj_org_article_e84dd4a53baf465dbedbaafa6b922ee4
PMC11130326
38802350
10_1038_s41467_024_48754_8
Genre Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 32170936
  funderid: https://doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 32170936
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M48
M7P
M~E
NADUK
NAO
NXXTH
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
SOI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c541t-d02863b46c56c797cace3aaaa9b5d9b95e9252f6970211516171ee49efbeeb913
IEDL.DBID M48
ISSN 2041-1723
IngestDate Wed Aug 27 01:00:30 EDT 2025
Thu Aug 21 18:33:48 EDT 2025
Fri Jul 11 12:02:31 EDT 2025
Wed Aug 13 09:17:20 EDT 2025
Thu Apr 03 06:57:08 EDT 2025
Thu Apr 24 22:50:46 EDT 2025
Tue Jul 01 02:11:09 EDT 2025
Fri Feb 21 02:39:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-d02863b46c56c797cace3aaaa9b5d9b95e9252f6970211516171ee49efbeeb913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8607-3750
0000-0002-0289-2941
0000-0001-6988-2791
0000-0001-6335-3346
0000-0002-6489-4459
0000-0002-2605-3747
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-024-48754-8
PMID 38802350
PQID 3060635056
PQPubID 546298
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_e84dd4a53baf465dbedbaafa6b922ee4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11130326
proquest_miscellaneous_3061137170
proquest_journals_3060635056
pubmed_primary_38802350
crossref_primary_10_1038_s41467_024_48754_8
crossref_citationtrail_10_1038_s41467_024_48754_8
springer_journals_10_1038_s41467_024_48754_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-05-27
PublicationDateYYYYMMDD 2024-05-27
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-27
  day: 27
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Lim (CR44) 2023; 161
Wan (CR7) 2023; 5
Ferré VM (CR19) 2022; 175
Suñer (CR10) 2023; 23
Endo (CR69) 2022; 378
Yang (CR58) 2023; 11
Petersen (CR65) 2019; 33
Nakhaie (CR23) 2023; 33
Towns (CR11) 2023; 4
Zeng (CR53) 2023; 12
Li (CR71) 2021; 12
Gould (CR49) 2022; 3
Kelley (CR48) 2017; 10
Català (CR43) 2022; 187
Colavita (CR36) 2023; 95
Atkinson (CR50) 2022; 24
Elsayed, Bondy, Hanage (CR68) 2022; 35
Rao (CR26) 2022; 71
Beeson (CR9) 2023; 4
Hasso (CR17) 2022; 28
Otu, Ebenso, Walley, Barceló, Ochu (CR22) 2022; 3
Zaeck (CR28) 2023; 29
Lim (CR35) 2023; 95
De Baetselier (CR20) 2022; 28
Pan (CR63) 2022; 399
Pfeiffer (CR32) 2022; 71
Lum (CR4) 2022; 22
Moschese (CR46) 2022; 27
Yang (CR34) 2020; 1
Yang (CR60) 2022; 7
Hubert (CR61) 2023; 31
Xu (CR27) 2023; 30
Lapa (CR16) 2022; 22
Zhang (CR54) 2023; 12
Hernaez (CR13) 2023; 4
Ogoina, Ogunsola (CR51) 2022; 3
Yang (CR72) 2022; 7
Mitjà (CR1) 2023; 401
Isidro (CR3) 2022; 28
Yu (CR30) 2023; 14
Fang (CR55) 2023; 33
Zhao (CR5) 2022; 4
Peiró-Mestres (CR15) 2022; 27
Wang, Yang, Zhou (CR29) 2023; 245
Bunge (CR66) 2022; 16
Reda, El-Qushayri, Shah (CR21) 2023; 4
Freyn (CR52) 2023; 15
Paran (CR45) 2022; 27
Palich (CR12) 2023; 23
Xu, Zhang (CR8) 2023; 87
Antinori (CR39) 2022; 27
Kim (CR47) 2023; 30
Jezek, Grab, Dixon (CR67) 1987; 126
Reed (CR2) 2004; 350
Yang (CR56) 2023; 95
Beer, Rao (CR64) 2019; 13
Huang, Mu, Wang (CR25) 2022; 7
Rizzo (CR18) 2023; 86
Thornhill (CR40) 2022; 387
Patel (CR41) 2022; 378
Sahay (CR31) 2023; 137
Zhao (CR33) 2020; 159
Hou (CR57) 2023; 14
Jiang (CR59) 2023; 95
CR62
Tarín-Vicente (CR42) 2022; 400
Cohn (CR37) 2023; 23
Yang (CR38) 2023; 4
Xu (CR70) 2024; 12
Dou (CR6) 2023; 12
Callaby (CR14) 2023; 135
Adler (CR24) 2022; 22
Y Yang (48754_CR72) 2022; 7
C Suñer (48754_CR10) 2023; 23
X Yang (48754_CR58) 2023; 11
T Li (48754_CR71) 2021; 12
A Rizzo (48754_CR18) 2023; 86
EM Beer (48754_CR64) 2019; 13
D Lapa (48754_CR16) 2022; 22
Y Yang (48754_CR60) 2022; 7
JA Pfeiffer (48754_CR32) 2022; 71
Y Jiang (48754_CR59) 2023; 95
Ferré VM (48754_CR19) 2022; 175
J Yu (48754_CR30) 2023; 14
CF Kelley (48754_CR48) 2017; 10
RR Sahay (48754_CR31) 2023; 137
A Otu (48754_CR22) 2022; 3
Y Yang (48754_CR38) 2023; 4
EM Bunge (48754_CR66) 2022; 16
Z Jezek (48754_CR67) 1987; 126
Y Yang (48754_CR34) 2020; 1
Z Fang (48754_CR55) 2023; 33
M Hasso (48754_CR17) 2022; 28
M Nakhaie (48754_CR23) 2023; 33
A Antinori (48754_CR39) 2022; 27
B Hernaez (48754_CR13) 2023; 4
H Cohn (48754_CR37) 2023; 23
Z Xu (48754_CR70) 2024; 12
H Adler (48754_CR24) 2022; 22
H Kim (48754_CR47) 2023; 30
Y Wang (48754_CR29) 2023; 245
JM Towns (48754_CR11) 2023; 4
KD Reed (48754_CR2) 2004; 350
H Callaby (48754_CR14) 2023; 135
A Català (48754_CR43) 2022; 187
X Yang (48754_CR56) 2023; 95
I De Baetselier (48754_CR20) 2022; 28
A Peiró-Mestres (48754_CR15) 2022; 27
B Atkinson (48754_CR50) 2022; 24
RR Zhang (48754_CR54) 2023; 12
S Gould (48754_CR49) 2022; 3
R Palich (48754_CR12) 2023; 23
F Zhao (48754_CR33) 2020; 159
D Moschese (48754_CR46) 2022; 27
J Wan (48754_CR7) 2023; 5
A Patel (48754_CR41) 2022; 378
F Hou (48754_CR57) 2023; 14
J Isidro (48754_CR3) 2022; 28
S Elsayed (48754_CR68) 2022; 35
O Mitjà (48754_CR1) 2023; 401
CK Lim (48754_CR44) 2023; 161
LM Zaeck (48754_CR28) 2023; 29
D Pan (48754_CR63) 2022; 399
AW Freyn (48754_CR52) 2023; 15
X Dou (48754_CR6) 2023; 12
T Xu (48754_CR8) 2023; 87
H Zhao (48754_CR5) 2022; 4
Y Huang (48754_CR25) 2022; 7
M Xu (48754_CR27) 2023; 30
CK Lim (48754_CR35) 2023; 95
M Hubert (48754_CR61) 2023; 31
JP Thornhill (48754_CR40) 2022; 387
FM Lum (48754_CR4) 2022; 22
D Ogoina (48754_CR51) 2022; 3
EJ Tarín-Vicente (48754_CR42) 2022; 400
A Beeson (48754_CR9) 2023; 4
F Colavita (48754_CR36) 2023; 95
A Reda (48754_CR21) 2023; 4
A Endo (48754_CR69) 2022; 378
N Paran (48754_CR45) 2022; 27
E Petersen (48754_CR65) 2019; 33
AK Rao (48754_CR26) 2022; 71
J Zeng (48754_CR53) 2023; 12
48754_CR62
References_xml – volume: 137
  start-page: 86
  year: 2023
  end-page: 88
  ident: CR31
  article-title: Persistence of infectious mpox virus on the surfaces of isolation ward in a hospital setting, India
  publication-title: J. Hosp. Infect.
  doi: 10.1016/j.jhin.2023.03.026
– volume: 7
  start-page: 423
  year: 2022
  end-page: 433
  ident: CR72
  article-title: Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-021-01051-2
– volume: 87
  start-page: e73
  year: 2023
  end-page: e74
  ident: CR8
  article-title: Rising prevalence of mpox in China, Japan, and Republic of Korea
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2023.07.017
– volume: 33
  year: 2023
  ident: CR23
  article-title: Monkeypox virus diagnosis and laboratory testing
  publication-title: Rev. Med Virol.
  doi: 10.1002/rmv.2404
– volume: 12
  year: 2023
  ident: CR6
  article-title: Clinical, epidemiological, and virological features of Mpox in Beijing, China - May 31-June 21, 2023
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2023.2254407
– volume: 28
  start-page: 2288
  year: 2022
  end-page: 2292
  ident: CR20
  article-title: Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-02004-w
– volume: 159
  start-page: 1158
  year: 2020
  end-page: 1160.e1152
  ident: CR33
  article-title: The Time Sequences of Respiratory and Rectal Viral Shedding in Patients With Coronavirus Disease 2019
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.05.035
– volume: 12
  year: 2021
  ident: CR71
  article-title: Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-25997-3
– volume: 7
  start-page: 316
  year: 2022
  ident: CR60
  article-title: Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-022-01166-w
– volume: 27
  start-page: 2200503
  year: 2022
  ident: CR15
  article-title: Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.28.2200503
– volume: 5
  start-page: 259
  year: 2023
  end-page: 265
  ident: CR7
  article-title: Investigation into the epidemiology, genetic characteristics, and clinical manifestations of the first monkeypox outbreak in Shenzhen, China
  publication-title: Biosaf. Health
  doi: 10.1016/j.bsheal.2023.08.001
– volume: 3
  start-page: e554
  year: 2022
  end-page: e555
  ident: CR22
  article-title: Global human monkeypox outbreak: atypical presentation demanding urgent public health action
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00153-7
– volume: 95
  year: 2023
  ident: CR59
  article-title: Various mpox recombinant subunits induce broadly reactive antibodies against orthopoxvirus in mice
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.28983
– volume: 22
  start-page: 1267
  year: 2022
  end-page: 1269
  ident: CR16
  article-title: Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00513-8
– volume: 7
  start-page: 373
  year: 2022
  ident: CR25
  article-title: Monkeypox: epidemiology, pathogenesis, treatment and prevention
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-022-01215-4
– volume: 30
  start-page: taad048
  year: 2023
  ident: CR27
  article-title: Real-world effectiveness of monkeypox vaccines: a systematic review
  publication-title: J. Travel Med.
  doi: 10.1093/jtm/taad048
– volume: 378
  start-page: e072410
  year: 2022
  ident: CR41
  article-title: Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series
  publication-title: Bmj
  doi: 10.1136/bmj-2022-072410
– volume: 4
  start-page: 853
  year: 2022
  end-page: 854
  ident: CR5
  article-title: The First Imported Case of Monkeypox in the Mainland of China - Chongqing Municipality, China, September 16, 2022
  publication-title: China CDC Wkly
– volume: 13
  start-page: e0007791
  year: 2019
  ident: CR64
  article-title: A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0007791
– volume: 27
  start-page: 2200675
  year: 2022
  ident: CR46
  article-title: Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.36.2200675
– volume: 378
  start-page: 90
  year: 2022
  end-page: 94
  ident: CR69
  article-title: Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022
  publication-title: Science
  doi: 10.1126/science.add4507
– volume: 400
  start-page: 661
  year: 2022
  end-page: 669
  ident: CR42
  article-title: Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)01436-2
– volume: 27
  start-page: 2200636
  year: 2022
  ident: CR45
  article-title: Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.35.2200636
– volume: 95
  year: 2023
  ident: CR56
  article-title: Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice
  publication-title: J. Med Virol.
  doi: 10.1002/jmv.29140
– volume: 33
  start-page: 407
  year: 2023
  end-page: 410
  ident: CR55
  article-title: Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens
  publication-title: Cell Res.
  doi: 10.1038/s41422-023-00792-5
– volume: 71
  start-page: 1092
  year: 2022
  end-page: 1094
  ident: CR32
  article-title: High-Contact Object and Surface Contamination in a Household of Persons with Monkeypox Virus Infection - Utah, June 2022
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm7134e1
– volume: 95
  year: 2023
  ident: CR35
  article-title: Mpox diagnostics: Review of current and emerging technologies
  publication-title: J. Med Virol.
  doi: 10.1002/jmv.28429
– volume: 33
  start-page: 1027
  year: 2019
  end-page: 1043
  ident: CR65
  article-title: Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention
  publication-title: Infect. Dis. Clin. North Am.
  doi: 10.1016/j.idc.2019.03.001
– volume: 28
  start-page: 1569
  year: 2022
  end-page: 1572
  ident: CR3
  article-title: Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-01907-y
– volume: 28
  start-page: 2513
  year: 2022
  end-page: 2515
  ident: CR17
  article-title: Monkeypox Virus Detection in Different Clinical Specimen Types
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2812.221160
– volume: 11
  start-page: 1420
  year: 2023
  ident: CR58
  article-title: A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice
  publication-title: Vaccines (Basel)
  doi: 10.3390/vaccines11091420
– volume: 35
  year: 2022
  ident: CR68
  article-title: Monkeypox Virus Infections in Humans
  publication-title: Clin. Microbiol Rev.
  doi: 10.1128/cmr.00092-22
– volume: 4
  start-page: e632
  year: 2023
  end-page: e641
  ident: CR38
  article-title: Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(23)00139-8
– volume: 23
  start-page: 74
  year: 2023
  end-page: 80
  ident: CR12
  article-title: Viral loads in clinical samples of men with monkeypox virus infection: a French case series
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00586-2
– volume: 16
  start-page: e0010141
  year: 2022
  ident: CR66
  article-title: The changing epidemiology of human monkeypox-A potential threat? A systematic review
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0010141
– volume: 12
  year: 2024
  ident: CR70
  article-title: Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant Klebsiella pneumoniae
  publication-title: Microbiol Spectr.
  doi: 10.1128/spectrum.00719-23
– volume: 3
  start-page: e889
  year: 2022
  end-page: e890
  ident: CR51
  article-title: Monkeypox and the health-care environment
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00286-5
– volume: 14
  year: 2023
  ident: CR30
  article-title: Phylogeny and molecular evolution of the first local monkeypox virus cluster in Guangdong Province, China
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-44092-3
– volume: 15
  year: 2023
  ident: CR52
  article-title: An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.adg3540
– volume: 1
  year: 2020
  ident: CR34
  article-title: Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection
  publication-title: Innov. (Camb.)
– volume: 12
  year: 2023
  ident: CR54
  article-title: Rational development of multicomponent mRNA vaccine candidates against mpox
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2023.2192815
– volume: 4
  start-page: e210
  year: 2023
  ident: CR11
  article-title: Persistence of monkeypox virus at oral and rectal sites
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00382-2
– volume: 126
  start-page: 1082
  year: 1987
  end-page: 1092
  ident: CR67
  article-title: Stochastic model for interhuman spread of monkeypox
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/oxfordjournals.aje.a114747
– volume: 12
  year: 2023
  ident: CR53
  article-title: Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2023.2204151
– volume: 135
  start-page: 139
  year: 2023
  end-page: 144
  ident: CR14
  article-title: Monkeypox virus isolation from longitudinal samples from four patients to infer risk of onwards transmission: an interim analysis
  publication-title: J. Hosp. Infect.
  doi: 10.1016/j.jhin.2023.03.009
– volume: 86
  start-page: 154
  year: 2023
  end-page: 225
  ident: CR18
  article-title: Role of multi-site sampling in the diagnosis of human Monkeypox
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2022.12.010
– volume: 399
  start-page: 2345
  year: 2022
  end-page: 2346
  ident: CR63
  article-title: Monkeypox in the UK: arguments for a broader case definition
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)01101-1
– volume: 387
  start-page: 679
  year: 2022
  end-page: 691
  ident: CR40
  article-title: Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2207323
– volume: 10
  start-page: 996
  year: 2017
  end-page: 1007
  ident: CR48
  article-title: The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention
  publication-title: Mucosal. Immunol.
  doi: 10.1038/mi.2016.97
– volume: 4
  start-page: e21
  year: 2023
  end-page: e28
  ident: CR13
  article-title: Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00291-9
– volume: 95
  year: 2023
  ident: CR36
  article-title: Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak
  publication-title: J. Med Virol.
  doi: 10.1002/jmv.28851
– volume: 161
  year: 2023
  ident: CR44
  article-title: Correlation between monkeypox viral load and infectious virus in clinical specimens
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2023.105421
– volume: 29
  start-page: 270
  year: 2023
  end-page: 278
  ident: CR28
  article-title: Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-02090-w
– volume: 3
  start-page: e904
  year: 2022
  end-page: e911
  ident: CR49
  article-title: Air and surface sampling for monkeypox virus in a UK hospital: an observational study
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00257-9
– volume: 350
  start-page: 342
  year: 2004
  end-page: 350
  ident: CR2
  article-title: The detection of monkeypox in humans in the Western Hemisphere
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa032299
– volume: 4
  start-page: e277
  year: 2023
  end-page: e283
  ident: CR9
  article-title: Mpox respiratory transmission: the state of the evidence
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(23)00034-4
– volume: 30
  start-page: taad111
  year: 2023
  ident: CR47
  article-title: Viral load dynamics and shedding kinetics of mpox infection: a systematic review and meta-analysis
  publication-title: J. Travel Med.
  doi: 10.1093/jtm/taad111
– volume: 27
  start-page: 2200421
  year: 2022
  ident: CR39
  article-title: Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.22.2200421
– volume: 401
  start-page: 60
  year: 2023
  end-page: 74
  ident: CR1
  article-title: Monkeypox
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)02075-X
– volume: 24
  start-page: 4561
  year: 2022
  end-page: 4569
  ident: CR50
  article-title: Infection-competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK
  publication-title: Environ. Microbiol
  doi: 10.1111/1462-2920.16129
– volume: 23
  start-page: 445
  year: 2023
  end-page: 453
  ident: CR10
  article-title: Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00794-0
– volume: 4
  start-page: e15
  year: 2023
  end-page: e16
  ident: CR21
  article-title: Asymptomatic monkeypox infection: a call for greater control of infection and transmission
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00259-2
– volume: 22
  start-page: 1153
  year: 2022
  end-page: 1162
  ident: CR24
  article-title: Clinical features and management of human monkeypox: a retrospective observational study in the UK
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00228-6
– volume: 14
  year: 2023
  ident: CR57
  article-title: mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-41628-5
– volume: 245
  year: 2023
  ident: CR29
  article-title: Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review
  publication-title: Int J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2023.125515
– volume: 23
  start-page: 1302
  year: 2023
  end-page: 1312
  ident: CR37
  article-title: Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(23)00352-3
– volume: 22
  start-page: 597
  year: 2022
  end-page: 613
  ident: CR4
  article-title: Monkeypox: disease epidemiology, host immunity and clinical interventions
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-022-00775-4
– volume: 187
  start-page: 765
  year: 2022
  end-page: 772
  ident: CR43
  article-title: Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases
  publication-title: Br. J. Dermatol
  doi: 10.1111/bjd.21790
– ident: CR62
– volume: 71
  start-page: 734
  year: 2022
  end-page: 742
  ident: CR26
  article-title: Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm7122e1
– volume: 175
  start-page: 1491
  year: 2022
  end-page: 1492
  ident: CR19
  article-title: Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France
  publication-title: Ann. Intern Med.
  doi: 10.7326/M22-2183
– volume: 31
  start-page: 937
  year: 2023
  end-page: 948.e934
  ident: CR61
  article-title: Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2023.05.001
– volume: 4
  start-page: 853
  year: 2022
  ident: 48754_CR5
  publication-title: China CDC Wkly
– volume: 29
  start-page: 270
  year: 2023
  ident: 48754_CR28
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-02090-w
– volume: 31
  start-page: 937
  year: 2023
  ident: 48754_CR61
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2023.05.001
– volume: 12
  year: 2021
  ident: 48754_CR71
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-25997-3
– volume: 95
  year: 2023
  ident: 48754_CR36
  publication-title: J. Med Virol.
  doi: 10.1002/jmv.28851
– volume: 27
  start-page: 2200675
  year: 2022
  ident: 48754_CR46
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.36.2200675
– volume: 27
  start-page: 2200421
  year: 2022
  ident: 48754_CR39
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.22.2200421
– volume: 28
  start-page: 2513
  year: 2022
  ident: 48754_CR17
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2812.221160
– volume: 4
  start-page: e21
  year: 2023
  ident: 48754_CR13
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00291-9
– volume: 400
  start-page: 661
  year: 2022
  ident: 48754_CR42
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)01436-2
– volume: 187
  start-page: 765
  year: 2022
  ident: 48754_CR43
  publication-title: Br. J. Dermatol
  doi: 10.1111/bjd.21790
– volume: 12
  year: 2024
  ident: 48754_CR70
  publication-title: Microbiol Spectr.
  doi: 10.1128/spectrum.00719-23
– volume: 30
  start-page: taad111
  year: 2023
  ident: 48754_CR47
  publication-title: J. Travel Med.
  doi: 10.1093/jtm/taad111
– volume: 23
  start-page: 74
  year: 2023
  ident: 48754_CR12
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00586-2
– volume: 7
  start-page: 316
  year: 2022
  ident: 48754_CR60
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-022-01166-w
– volume: 86
  start-page: 154
  year: 2023
  ident: 48754_CR18
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2022.12.010
– volume: 16
  start-page: e0010141
  year: 2022
  ident: 48754_CR66
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0010141
– volume: 4
  start-page: e210
  year: 2023
  ident: 48754_CR11
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00382-2
– volume: 95
  year: 2023
  ident: 48754_CR59
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.28983
– volume: 27
  start-page: 2200503
  year: 2022
  ident: 48754_CR15
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.28.2200503
– volume: 35
  year: 2022
  ident: 48754_CR68
  publication-title: Clin. Microbiol Rev.
  doi: 10.1128/cmr.00092-22
– volume: 5
  start-page: 259
  year: 2023
  ident: 48754_CR7
  publication-title: Biosaf. Health
  doi: 10.1016/j.bsheal.2023.08.001
– volume: 3
  start-page: e904
  year: 2022
  ident: 48754_CR49
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00257-9
– volume: 4
  start-page: e277
  year: 2023
  ident: 48754_CR9
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(23)00034-4
– volume: 3
  start-page: e554
  year: 2022
  ident: 48754_CR22
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00153-7
– volume: 12
  year: 2023
  ident: 48754_CR6
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2023.2254407
– volume: 175
  start-page: 1491
  year: 2022
  ident: 48754_CR19
  publication-title: Ann. Intern Med.
  doi: 10.7326/M22-2183
– volume: 7
  start-page: 373
  year: 2022
  ident: 48754_CR25
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-022-01215-4
– volume: 1
  year: 2020
  ident: 48754_CR34
  publication-title: Innov. (Camb.)
– volume: 12
  year: 2023
  ident: 48754_CR53
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2023.2204151
– volume: 22
  start-page: 1153
  year: 2022
  ident: 48754_CR24
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00228-6
– volume: 22
  start-page: 1267
  year: 2022
  ident: 48754_CR16
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00513-8
– volume: 378
  start-page: e072410
  year: 2022
  ident: 48754_CR41
  publication-title: Bmj
  doi: 10.1136/bmj-2022-072410
– volume: 14
  year: 2023
  ident: 48754_CR57
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-41628-5
– volume: 10
  start-page: 996
  year: 2017
  ident: 48754_CR48
  publication-title: Mucosal. Immunol.
  doi: 10.1038/mi.2016.97
– volume: 30
  start-page: taad048
  year: 2023
  ident: 48754_CR27
  publication-title: J. Travel Med.
  doi: 10.1093/jtm/taad048
– volume: 3
  start-page: e889
  year: 2022
  ident: 48754_CR51
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00286-5
– volume: 399
  start-page: 2345
  year: 2022
  ident: 48754_CR63
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)01101-1
– volume: 24
  start-page: 4561
  year: 2022
  ident: 48754_CR50
  publication-title: Environ. Microbiol
  doi: 10.1111/1462-2920.16129
– volume: 87
  start-page: e73
  year: 2023
  ident: 48754_CR8
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2023.07.017
– volume: 387
  start-page: 679
  year: 2022
  ident: 48754_CR40
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2207323
– volume: 14
  year: 2023
  ident: 48754_CR30
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-44092-3
– volume: 33
  start-page: 407
  year: 2023
  ident: 48754_CR55
  publication-title: Cell Res.
  doi: 10.1038/s41422-023-00792-5
– volume: 95
  year: 2023
  ident: 48754_CR35
  publication-title: J. Med Virol.
  doi: 10.1002/jmv.28429
– volume: 33
  year: 2023
  ident: 48754_CR23
  publication-title: Rev. Med Virol.
  doi: 10.1002/rmv.2404
– volume: 7
  start-page: 423
  year: 2022
  ident: 48754_CR72
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-021-01051-2
– volume: 33
  start-page: 1027
  year: 2019
  ident: 48754_CR65
  publication-title: Infect. Dis. Clin. North Am.
  doi: 10.1016/j.idc.2019.03.001
– volume: 23
  start-page: 445
  year: 2023
  ident: 48754_CR10
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00794-0
– volume: 4
  start-page: e632
  year: 2023
  ident: 48754_CR38
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(23)00139-8
– volume: 159
  start-page: 1158
  year: 2020
  ident: 48754_CR33
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.05.035
– volume: 27
  start-page: 2200636
  year: 2022
  ident: 48754_CR45
  publication-title: Eur. Surveill.
  doi: 10.2807/1560-7917.ES.2022.27.35.2200636
– volume: 13
  start-page: e0007791
  year: 2019
  ident: 48754_CR64
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0007791
– volume: 137
  start-page: 86
  year: 2023
  ident: 48754_CR31
  publication-title: J. Hosp. Infect.
  doi: 10.1016/j.jhin.2023.03.026
– volume: 4
  start-page: e15
  year: 2023
  ident: 48754_CR21
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(22)00259-2
– volume: 126
  start-page: 1082
  year: 1987
  ident: 48754_CR67
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/oxfordjournals.aje.a114747
– volume: 71
  start-page: 1092
  year: 2022
  ident: 48754_CR32
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm7134e1
– volume: 28
  start-page: 2288
  year: 2022
  ident: 48754_CR20
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-02004-w
– volume: 350
  start-page: 342
  year: 2004
  ident: 48754_CR2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa032299
– volume: 28
  start-page: 1569
  year: 2022
  ident: 48754_CR3
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-01907-y
– volume: 12
  year: 2023
  ident: 48754_CR54
  publication-title: Emerg. Microbes Infect.
  doi: 10.1080/22221751.2023.2192815
– ident: 48754_CR62
  doi: 10.2139/ssrn.4578561
– volume: 401
  start-page: 60
  year: 2023
  ident: 48754_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)02075-X
– volume: 71
  start-page: 734
  year: 2022
  ident: 48754_CR26
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm7122e1
– volume: 135
  start-page: 139
  year: 2023
  ident: 48754_CR14
  publication-title: J. Hosp. Infect.
  doi: 10.1016/j.jhin.2023.03.009
– volume: 11
  start-page: 1420
  year: 2023
  ident: 48754_CR58
  publication-title: Vaccines (Basel)
  doi: 10.3390/vaccines11091420
– volume: 245
  year: 2023
  ident: 48754_CR29
  publication-title: Int J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2023.125515
– volume: 23
  start-page: 1302
  year: 2023
  ident: 48754_CR37
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(23)00352-3
– volume: 161
  year: 2023
  ident: 48754_CR44
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2023.105421
– volume: 378
  start-page: 90
  year: 2022
  ident: 48754_CR69
  publication-title: Science
  doi: 10.1126/science.add4507
– volume: 22
  start-page: 597
  year: 2022
  ident: 48754_CR4
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-022-00775-4
– volume: 15
  year: 2023
  ident: 48754_CR52
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.adg3540
– volume: 95
  year: 2023
  ident: 48754_CR56
  publication-title: J. Med Virol.
  doi: 10.1002/jmv.29140
SSID ssj0000391844
Score 2.5214648
Snippet Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple body sites...
Abstract Understanding of infection dynamics is important for public health measures against monkeypox virus (MPXV) infection. Herein, samples from multiple...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4488
SubjectTerms 45/23
49/22
631/326/2521
631/326/596/1746
692/699/255/2514
82/1
Adult
Air conditioning
Antibodies
Antibodies, Neutralizing - blood
Antibodies, Neutralizing - immunology
Antibodies, Viral - blood
Antibodies, Viral - immunology
Antibody response
Coinfection - epidemiology
Coinfection - immunology
Coinfection - virology
Deoxyribonucleic acid
DNA
DNA, Viral
Fomites
Fomites - virology
HIV
HIV Infections - immunology
HIV Infections - virology
Human immunodeficiency virus
Humanities and Social Sciences
Humans
Immunoglobulin G
Infections
Lesions
Longitudinal Studies
Male
Middle Aged
Monkeypox virus - immunology
Mpox
Mpox, Monkeypox - epidemiology
Mpox, Monkeypox - immunology
Mpox, Monkeypox - virology
multidisciplinary
Neutralizing
Oropharynx
Oropharynx - immunology
Oropharynx - virology
Prospective Studies
Public health
Rectum
Saliva
Saliva - immunology
Saliva - virology
Science
Science (multidisciplinary)
Skin
Skin diseases
Skin lesions
Viral Load
Virus Shedding
Viruses
SummonAdditionalLinks – databaseName: Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDeBgozEDaLG8SMxN0BUFQJOVOrN8mOsVipJtZtI9D_woxk7ydLwvLDSXtZ24vXMZL6Jx98Q8rx2wnNQsmSRV6UITpY6qlBKbgWiWYcuKp0d_vhJHR2L9yfy5Eqpr5QTNtEDTwt3AK0IQVjJnY1CyeAgOGujVU7XNUBmAsULXgmm8jOYawxdxHxKpuLtwVbkZwK6pDJhdFG2K0-UCft_hzJ_TZb8acc0O6LDW-TmjCDp62nmt8k16O6Q61NNycu75NuHPpUgGkMqd0VTCu853Z5CSD6K2i7gdzhzfbikmyk9FqhfkzbTPtIv0NH0ipZaPw5Al5StLrf1HVr-Rf81XX3cvqKW4v9ZjmzSVHJ3M9DMW3uPHB---_z2qJxLLpReCjaUAeGG4k4oL5VvdOOtB27xo50M2mkJupZ1VLpBbIBgAfEPQyFoiA7Aacbvk72u7-AhoaHhInIXMQJ2ovLOMggY_1SRNZG3oi4IW5bf-JmPPJXFODd5X5y3ZhKZQZGZLDLTFuTFbszFxMbx195vklR3PROTdv4B9cvM-mX-pV8F2V90wszmvTUYZyG0S-CxIM92zWiYabfFdtCPuQ9jHKPlqiAPJhXazSQx8NQ4viDtSrlWU123dGenmfwbfROijhpv_HLRwx_z-vNaPPofa_GY3KiTAVXpGOM-2Rs2IzxBTDa4p9n8vgO-vzhR
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwELagCAmpQlCuQEFG4g2sxrGdgxcEiKVCwBOV-hb5pJVKst0kEv0P_GhmnKNajkbKS-xk7Z0Zz-fxHIS8yIy0wueK8SBSJp1RrAq5Y0poCWjWgIrC2OEvX_PDI_npWB1PBrducquc18S4ULvWoo38AKAtaFPU12_W5wyrRuHp6lRC4zq5wUHToEtXufq42Fgw-3kp5RQrk4ryoJNxZQDFxBCpS1Zu6aOYtv9fWPNvl8k_zk2jOlrdIbcnHEnfjoS_S675Zo_cHCtLXuyR3dEcR8coo3vk1-cWCxMNDotgUXTsPaPdiXeouahuHNz9qWndBd2MTrOe2u1UzrQN9IdvKBpuqbZD7-nsyNXEtraB9WDd_sSvD91rqinMbw7kpFiId9PTmM32Pjlaffj2_pBNhRiYVZL3zAEIyYWRuVW5LarCauuFhqsyylWmUr7KVBbyqgDEABACUBH3XlY-GO9NxcUDstO0jX9EqCuEDMIE2BcbmVqjuXewK0oDL4IoZZYQPpOjtlOWciyWcVbH03JR1iMJayBhHUlYlwl5ubyzHnN0XNn7HVJ56Yn5teODdvO9nsS19qV0TmoljA4yV854Z7QOOjdVlsHUErI_80g9CX1XX7JoQp4vzSCueAajG98OsQ_nAvbQaUIejiy1jATz8mTwfkLKLWbbGup2S3N6ElOCg8YCLJLBD7-a-fJyXP__Lx5fPY0n5FaGopJi2OI-2ek3g38KGKw3z6Kg_QagBzIM
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1da9YwFA5zQ_BG_LY6JYJ3Wmzz0TbevYpjvKg3OthdyKcbbOl43xbcf9iP3kn6IdUpWOhNk7Rpc07Pk-Sc5yD0mmhmqKt4Xnpa5Mxqngtf2ZxTxQDNajBRMXb4y9fq8Iitj_nxDiJTLExy2k-Uluk3PXmHvduypNJgUfIIsVne3EJ7kaodZHtvtVp_W88rK5HzvGFsjJApaHND44UVSmT9NyHMPx0lf9stTUbo4B66O6JHvBr6ex_tuPAA3R7ySV4-RFef25h-qLcx1RWO7rtneHvibLRPWAULZ3eqW3uJN4NrrMNmSdiMW4_PXcBxeRYr03cOT-5aIZW1AbT-ov0Z795v32OF4X2mcE0c0-1uOpw4ax-ho4NP3z8e5mO6hdxwVna5BahRUc0qwytTi9oo46iCQ2huhRbcCcKJr0QNuACAAmCf0jkmnNfOaVHSx2g3tME9RdjWlHmqPcx-NSuMVqWzMPcpfFl72jCSoXL6_NKMXOQxJcaZTHvitJHDkEkYMpmGTDYZejO3uRiYOP5Z-0Mc1blmZNFOF9rNDzlKlXQNs5YpTrXyrOJWO6uV8qrSghB4tQztTzIhR9XeSphjAayLwDFDr-ZiUMq406KCa_tUpywpzJSLDD0ZRGjuSWTfIdA-Q81CuBZdXZaE05NE_A12CRAHgQe_neTwV7_-_i2e_V_15-gOiapSxGDFfbTbbXr3ApBXp1-OqnYNpv0sZg
  priority: 102
  providerName: Springer Nature
Title Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study
URI https://link.springer.com/article/10.1038/s41467-024-48754-8
https://www.ncbi.nlm.nih.gov/pubmed/38802350
https://www.proquest.com/docview/3060635056
https://www.proquest.com/docview/3061137170
https://pubmed.ncbi.nlm.nih.gov/PMC11130326
https://doaj.org/article/e84dd4a53baf465dbedbaafa6b922ee4
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1tb9MwED7tRUh8QbwTGJWR-AaBJraTGAmhrlqZKjYhoFK_RXZss0klGWkqrf-BH83ZSYoKhU9USivFduPYd7nnYt89AM9jxQpqEh5Glg5DphUPhU10yKlkiGYVmigXO3x2npzO2HTO53vQ0x11A7jc6do5PqlZvXh1_X39DhX-bRsynr1eMq_uaG1CB79ZmO3DIVqm1DEanHVw3z-ZqUCHhnWxM7ubbtknn8Z_F_b8cwvlb-uo3jxNbsOtDleSUSsId2DPlHfhRss0ub4HPz5UjphopR0JFnEbexdkeWG0s1xElhqP5lJVek3qdtOsIcV2KmdSWfLNlMS9uCWyWDWG9Bu5Sl9Wlfg8uKqu3b-vlm-IJHg_fSAncUS8dUN8Ntv7MJucfBmfhh0RQ1hwFjWhRhCSUMWSgidFKtJCFoZK_AjFtVCCGxHz2CYiRcSAEAJRUWQME8YqY5SI6AM4KKvSPAKiU8osVRb9YsWGhZKR0egVDW2UWpqxOICoH_686LKUO7KMRe5Xy2mWt1OW45TlfsryLIAXmzZXbY6Of9Y-drO6qenya_sTVf0179Q1NxnTmklOlbQs4VoZraS0MlEijvHWAjjqZSLvZTZH7wsBn4OUATzbFKO6ujUYWZpq5etEEUUfehjAw1aENj1xeXlibB9AtiVcW13dLikvL3xKcLRYiEVivPDLXg5_9evvY_H4f4zFE7gZOwUauuDGIzho6pV5ikitUQPYT-cpfmeT9wM4HI2mn6f4e3xy_vETnh0n44F_BzLwavoTiFRFfQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKEQIJIShXoICR4AmiJj6yCRJCXMuWbvvUSn1zfYVWKsmymxXsf-C38BuZcZKtlqNvjbQvsZPYO-P5Zuw5CHnGjLDcZzJOS57EwhkZF2XmYsm1AG3WAERh7PDuXjY6EJ8P5eEa-dXHwqBbZS8Tg6B2tcU98i1QbQFNEa_fTL7FWDUKT1f7EhotW-z4xXcw2Wavtz8AfZ8zNvy4_34Ud1UFYitF2sQOEDXjRmRWZnZQDKy2nmu4CiNdYQrpCyZZmRUDgD_AQ4D41HtR-NJ4b4qUw3svkcuCA5JjZPrw03JPB7Ot50J0sTkJz7dmIkgiAMIYLQMR5yv4F8oE_Eu3_dtF849z2gB_w5vkRqe30rcto90ia77aIFfaSpaLDXK93f6jbVTTbfJzXGMhpLnDolsUHYlP6ezYO0RKqisHv-bE1G5Bp62Trqd2NXU0rUv61VcUN4qptvPG095xrAptdQXyZ1L_wLfPZ6-opjC_PnCUYuHfaUND9tw75OBCSHSXrFd15e8T6gZclNyUYIcbkVijU-_ACkvKdFDyXLCIpD05lO2yomNxjlMVTud5rloSKiChCiRUeUReLJ-ZtDlBzu39Dqm87In5vMONevpFdeJB-Vw4J7TkRpcik854Z7QudWYKxmBqEdnseUR1QmamzpZERJ4um0E84JmPrnw9D33SlIPNnkTkXstSy5FgHiAGz0ckX2G2laGutlQnxyEFOSAk6D4MPvyy58uzcf3_v3hw_jSekKuj_d2xGm_v7Twk1xgumwRDJjfJejOd-0eg_zXmcVh0lBxd9Cr_DdCNbyw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VrUBICEG5AgWMBE8QbRI7FxJClHbV0lJViEp9c-3YppVKsuxmBfsf-EX8OmZybLUcfWukfYmdxN4ZzzdjzwHwPNKi4DaJ_dDxwBdGx37uEuPHXAnUZjVCFMUOf9xPtg_Fh6P4aAV-9bEw5FbZy8RGUJuqoD3yIaq2iKaE10PXuUUcbI7ejr_5VEGKTlr7choti-za-Xc036ZvdjaR1i-iaLT1-f2231UY8ItYhLVvEF0TrkVSxEmR5mmhCssVXrmOTa7z2OZRHLkkTxEKERsR7kNrRW6dtlbnIcf3XoHVlKyiAaxubO0ffFrs8FDu9UyILlIn4NlwKhq5hLDok50g_GwJDZuiAf_SdP922Pzj1LYBw9EtuNlpsexdy3a3YcWWa3C1rWs5X4Mb7WYga2Oc7sDPvYrKIs0MleBi5FZ8xqYn1hBuMlUa_NWnujJzNmlddi0rlhNJs8qxr7ZktG3MVDGrLevdyMqmrSpRGo2rH_T22fQ1Uwzn14eRMioDPKlZk0v3LhxeCpHuwaCsSvsAmEm5cFw7tMq1CAqtQmvQJgtcmDqeiciDsCeHLLoc6VSq40w2Z_U8ky0JJZJQNiSUmQcvF8-M2wwhF_beICovelJ27-ZGNfkiO2EhbSaMESrmWjmRxEZbo5VyKtF5FOHUPFjveUR2ImcqzxeIB88WzSgs6ARIlbaaNX3CkKMFH3hwv2WpxUgoK1CEz3uQLTHb0lCXW8rTkyYhOeIlakIRfvhVz5fn4_r_f_Hw4mk8hWu4wuXezv7uI7ge0aoJKH5yHQb1ZGYfozJY6yfdqmNwfNkL_TfyzHS-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Longitudinal+viral+shedding+and+antibody+response+characteristics+of+men+with+acute+infection+of+monkeypox+virus%3A+a+prospective+cohort+study&rft.jtitle=Nature+communications&rft.au=Yang+Yang&rft.au=Shiyu+Niu&rft.au=Chenguang+Shen&rft.au=Liuqing+Yang&rft.date=2024-05-27&rft.pub=Nature+Portfolio&rft.eissn=2041-1723&rft.volume=15&rft.issue=1&rft.spage=1&rft.epage=12&rft_id=info:doi/10.1038%2Fs41467-024-48754-8&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e84dd4a53baf465dbedbaafa6b922ee4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon